Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLPHAR: Colistin PK/PD in Critically Ill Patients
NCT02408185Phase 1Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of colistin in Acinetobacter baumannii infection (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Pharmacokinetic profile; Cmax/MIC at Day 3. Started Oct 2011; status: completed.
02
Drugs
colistin
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on NCT02408185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408185.